Clinical Trial Update: Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase II feasibility study of dendritic cell vaccination for newly diagnosed glioblastoma multiforme completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Dendritic Cell Vaccination (dendritic cell vaccine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2012-09-26